A phase III study of radiation therapy plus carmustine with or without recombinant interferon-alpha in the treatment of patients with newly diagnosed high-grade glioma. [electronic resource]
Producer: 20010809Description: 420-33 p. digitalISSN:- 0008-543X
- Adult
- Aged
- Antineoplastic Agents -- administration & dosage
- Antineoplastic Agents, Alkylating -- administration & dosage
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Brain Neoplasms -- drug therapy
- Carmustine -- administration & dosage
- Combined Modality Therapy
- Disease Progression
- Female
- Glioma -- drug therapy
- Humans
- Interferon-alpha -- administration & dosage
- Male
- Middle Aged
- Neoplasm Staging
- Survival Analysis
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial; Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
There are no comments on this title.
Log in to your account to post a comment.